Conditions: Glaucoma, Open-Angle Ocular Hypertension
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 263
Healthy volunteers: no

Brief summary:
This is a study of bimatoprost as initial, replacement, or adjunctive intraocular pressure (IOP)-lowering therapy in patients with primary open angle glaucoma and ocular hypertension.

Detailed description:

Arms:
arm 1: Bimatoprost 0.03% (LUMIGAN®) 1 drop in the affected eye(s) once daily as monotherapy or adjunctive therapy for 3 months.

Interventions: intervention 1: Bimatoprost 0.03%
Intervention descriptions: intervention 1: Bimatoprost 0.03% (LUMIGAN®) 1 drop in the affected eye(s) once daily as monotherapy or adjunctive therapy for 3 months.

Protocol document: